These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34596803)

  • 1. Stromal tumor-infiltrating lymphocytes level as a prognostic factor for resected intrahepatic cholangiocarcinoma and its prediction by apparent diffusion coefficient.
    Miyazaki K; Morine Y; Yamada S; Saito Y; Tokuda K; Okikawa S; Yamashita S; Oya T; Ikemoto T; Imura S; Hu H; Morioka H; Tsuneyama K; Shimada M
    Int J Clin Oncol; 2021 Dec; 26(12):2265-2274. PubMed ID: 34596803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic prediction of apparent diffusion coefficient obtained by diffusion-weighted MRI in mass-forming intrahepatic cholangiocarcinoma.
    Yamada S; Morine Y; Imura S; Ikemoto T; Arakawa Y; Saito Y; Yoshikawa M; Miyazaki K; Shimada M
    J Hepatobiliary Pancreat Sci; 2020 Jul; 27(7):388-395. PubMed ID: 32162483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative lymphocyte/C-reactive protein ratio and its correlation with CD8
    Miyazaki K; Morine Y; Imura S; Ikemoto T; Saito Y; Yamada S; Tokuda K; Okikawa S; Yamashita S; Oya T; Tsuneyama K; Shimada M
    Surg Today; 2021 Dec; 51(12):1985-1995. PubMed ID: 34009433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative HALP score is a prognostic factor for intrahepatic cholangiocarcinoma patients undergoing curative hepatic resection: association with sarcopenia and immune microenvironment.
    Toshida K; Itoh S; Nakayama Y; Tsutsui Y; Kosai-Fujimoto Y; Tomino T; Yoshiya S; Nagao Y; Harada N; Kohashi K; Oda Y; Yoshizumi T
    Int J Clin Oncol; 2023 Aug; 28(8):1082-1091. PubMed ID: 37247134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of stromal tumor-infiltrating lymphocytes in intrahepatic cholangiocarcinoma: a population-based study.
    Qiang Z; Dai K; He Y; Yang Z; Tao L; Zhang H; Yu H
    Scand J Gastroenterol; 2022 Aug; 57(8):965-971. PubMed ID: 35522155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in node-negative intrahepatic cholangiocarcinoma with special reference to angiogenesis.
    Shirabe K; Shimada M; Tsujita E; Aishima S; Maehara S; Tanaka S; Takenaka K; Maehara Y
    Am J Surg; 2004 Apr; 187(4):538-42. PubMed ID: 15041507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of matrix metalloproteinase-7 is an unfavorable prognostic factor in intrahepatic cholangiocarcinoma.
    Hirashita T; Iwashita Y; Ohta M; Komori Y; Eguchi H; Yada K; Kitano S
    J Gastrointest Surg; 2012 Apr; 16(4):842-8. PubMed ID: 22246855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of L-type amino acid transporter 1 on intrahepatic cholangiocarcinoma.
    Selenge B; Yamada S; Morine Y; Ikemoto T; Saito Y; Takasu C; Teraoku H; Okikawa S; Shimada M
    J Med Invest; 2023; 70(1.2):160-165. PubMed ID: 37164714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass-forming intrahepatic cholangiocarcinoma: Can diffusion-weighted imaging predict microvascular invasion?
    Zhou Y; Wang X; Xu C; Zhou G; Liu X; Gao S; Xu P
    J Magn Reson Imaging; 2019 Jul; 50(1):315-324. PubMed ID: 30444023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent Diffusion Coefficient MRI Shows Association With Early Progression of Unresectable Intrahepatic Cholangiocarcinoma With Combined Targeted-Immunotherapy.
    Sheng R; Sun W; Huang X; Jin K; Gao S; Zeng M; Wu D; Shi G
    J Magn Reson Imaging; 2023 Jan; 57(1):275-284. PubMed ID: 35488518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic and hilar mass-forming cholangiocarcinoma: Qualitative and quantitative evaluation with diffusion-weighted MR imaging.
    Fattach HE; Dohan A; Guerrache Y; Dautry R; Boudiaf M; Hoeffel C; Soyer P
    Eur J Radiol; 2015 Aug; 84(8):1444-1451. PubMed ID: 26022518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incremental value of volumetric multiparametric MRI over Fudan score for prognosis of unresectable intrahepatic cholangiocarcinoma treated with systemic chemotherapy.
    Pandey A; Mohseni A; Shaghaghi M; Pandey P; Rezvani Habibabadi R; Hazhirkarzar B; Ly A; Panid Madani S; Borhani A; Kamel IR
    Eur J Radiol; 2024 Jan; 170():111196. PubMed ID: 38029705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Factor of Tumor Aggressiveness in Patients with Extrahepatic Cholangiocarcinoma Based on Diffusion-weighted MRI.
    Huang X; Shu J; Wang J
    Curr Med Imaging; 2024; 20():1-8. PubMed ID: 38389346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of diffusion-weighted MR imaging in the diagnosis of lymph node metastases in patients with cholangiocarcinoma.
    Holzapfel K; Gaa J; Schubert EC; Eiber M; Kleeff J; Rummeny EJ; Loos M
    Abdom Radiol (NY); 2016 Oct; 41(10):1937-41. PubMed ID: 27271285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of apparent diffusion coefficient values for the differentiation of intrahepatic cholangiocarcinoma from gastrointestinal adenocarcinoma liver metastases.
    Yilmaz TF; Gultekin MA; Turk HM; Besiroglu M; Cesme DH; Simsek M; Alkan A; Toprak H
    Radiol Oncol; 2021 Dec; 56(1):54-59. PubMed ID: 34957725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mass-forming Intrahepatic Cholangiocarcinoma: Diffusion-weighted Imaging as a Preoperative Prognostic Marker.
    Lee J; Kim SH; Kang TW; Song KD; Choi D; Jang KT
    Radiology; 2016 Oct; 281(1):119-28. PubMed ID: 27115053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apparent diffusion coefficient value of mass-forming intrahepatic cholangiocarcinoma: a potential imaging biomarker for prediction of lymph node metastasis.
    Zhou Y; Zhou G; Gao X; Xu C; Wang X; Xu P
    Abdom Radiol (NY); 2020 Oct; 45(10):3109-3118. PubMed ID: 32107582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of tumor-infiltrating lymphocytes in cholangiocarcinoma.
    Liu D; Heij LR; Czigany Z; Dahl E; Lang SA; Ulmer TF; Luedde T; Neumann UP; Bednarsch J
    J Exp Clin Cancer Res; 2022 Apr; 41(1):127. PubMed ID: 35392957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte-C-reactive protein ratio as a prognostic marker associated with the tumor immune microenvironment in intrahepatic cholangiocarcinoma.
    Yugawa K; Itoh S; Yoshizumi T; Morinaga A; Iseda N; Toshima T; Harada N; Kohashi K; Oda Y; Mori M
    Int J Clin Oncol; 2021 Oct; 26(10):1901-1910. PubMed ID: 34117554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.